16th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
Target: L4000
Target: L4000
Type: All-group target
Is protein multimer? Yes
Is CAPRI target? No
Is ligand target? Yes
Entry Date: 2024-05-03
Server Expiration Date: 2024-07-20
Human Expiration Date: 2024-08-03

Protein: MPro
Organism:
Residues: 306
Method: X-RAY
Additional Information: The Mpro dataset, generously provided by Idorsia Pharmaceuticals Ltd (Allschwil, CH), contains in total 25 protein-ligand(s) complexes. The structure is a homodimer. --- Tasks: 25 protein-ligand(s) complexes: ONLY Pose (P) prediction. --- The stereochemistry is known and is provided for all the ligands, however the protonation might not be optimal and would need to be determined. Some protein-ligand(s) complexes have more than one ligand present in the active site (20 protein-ligand(s) complexes in total). Molecules located nearby (<4.5 A) the main ligand(s) and interacting with specific or non-specific interactions were also included in the SMILES files (.tsv). --- Some ligands are covalently bound to a cysteine residue. The attachment points for each covalent inhibitor are as follows: L4003, LIG, SMARTS: [cX3][nX2][cX3][nX2] (first atom); L4013, LIG, SMARTS: [C](=[N])[c] (first atom); L4019, LIG, SMARTS: [C](=[N])[c] (first atom); L4023, LIG, SMARTS: [C](=[N])[c] (first atom). --- In L4007, Cys145 is chemically modified to S-Hydroperoxycysteine (https://pubchem.ncbi.nlm.nih.gov/compound/S-Hydroperoxycysteine). --- Reference: https://www.biorxiv.org/content/10.1101/2024.02.12.579977v1 --- Predicted protein-ligand complexes should be submitted in CASP LG format through a special ligand submission gateway: https://predictioncenter.org/casp16/predictions_submission_LG.cgi .
Sequence: (Plain text version)
Template: (Plain text version)
Ligand SMILES: (L4000.SMILES.tar.gz)
Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2024, University of California, Davis
Terms of Use